Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 07, 2018 16:05 ET | Source: GenMark Diagnostics, Inc.

GenMark Diagnostics to Present at Upcoming Investor Conferences

CARLSBAD, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced the...
October 29, 2018 16:05 ET | Source: GenMark Diagnostics, Inc.

GenMark Diagnostics Reports Third Quarter 2018 Results

CARLSBAD, Calif., Oct. 29, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced...
October 15, 2018 16:05 ET | Source: GenMark Diagnostics, Inc.

GenMark Diagnostics Schedules Third Quarter Financial Results Conference Call for October 29, 2018

CARLSBAD, Calif., Oct. 15, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its third quarter earnings results after market close on Monday,...
October 02, 2018 16:14 ET | Source: GenMark Diagnostics, Inc.

GenMark Diagnostics Announces FDA Submission of its ePlex Blood Culture Identification Gram-Negative and ePlex Blood Culture Identification Fungal Pathogen Panels

CARLSBAD, Calif., Oct. 02, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced the...
July 30, 2018 16:05 ET | Source: GenMark Diagnostics, Inc.

GenMark Diagnostics Reports Second Quarter 2018 Results

CARLSBAD, Calif., July 30, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced...
July 25, 2018 16:03 ET | Source: GenMark Diagnostics, Inc.

GenMark Diagnostics to Present at the Canaccord Genuity 38th Annual Growth Conference

CARLSBAD, Calif., July 25, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that...
July 16, 2018 17:31 ET | Source: GenMark Diagnostics, Inc.

GenMark Diagnostics Schedules Second Quarter Financial Results Conference Call for July 30, 2018

CARLSBAD, Calif., July 16, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK) today announced that it plans to release its second quarter earnings results after market close on Monday,...
June 28, 2018 16:57 ET | Source: GenMark Diagnostics, Inc.

GenMark Diagnostics Announces FDA Submission of its ePlex Blood Culture Identification Gram Positive Panel

CARLSBAD, Calif., June 28, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced...
June 06, 2018 08:00 ET | Source: GenMark Diagnostics, Inc.

GenMark Diagnostics to Present at the William Blair 38th Annual Growth Stock Conference

CARLSBAD, Calif., June 06, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that...
May 02, 2018 16:03 ET | Source: GenMark Diagnostics, Inc.

GenMark Diagnostics to Present at the Bank of America Merrill Lynch 2018 Health Care Conference

CARLSBAD, Calif., May 02, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK) a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that...